Universal Biosensors Inc Market Cap ($2.95 Million)
Market Cap & Net Worth: Universal Biosensors Inc (UBI)
Universal Biosensors Inc market cap. Universal Biosensors Inc (AU:UBI) has a market capitalization of $2.95 Million (AU$4.17 Million) as of November 8, 2026. Listed on the AU stock exchange, this Australia-based company holds position #29463 globally and #1644 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Universal Biosensors Inc's stock price AU$0.01 by its total outstanding shares 298067435 (298.07 Million). Also see UBI cash flow conversion for how efficiently the company converts equity into cash flow.
Universal Biosensors Inc Market Cap History (2015–2026)
Universal Biosensors Inc market cap history from 2015 to 2026. Data shows change from $94.91 Million to $2.95 Million (-26.44% CAGR). Check UBI share price today for real-time trading data and today's change.
Universal Biosensors Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Universal Biosensors Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Universal Biosensors Inc (UBI) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
3.52x
Universal Biosensors Inc's market cap is 3.52 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $94.91 Million | $16.77 Million | -$6.58 Million | 5.66x | N/A |
| 2016 | $65.38 Million | $18.83 Million | $1.25 Million | 3.47x | 52.29x |
| 2017 | $63.27 Million | $25.19 Million | -$764.72K | 2.51x | N/A |
| 2018 | $46.40 Million | $69.46 Million | $37.56 Million | 0.67x | 1.24x |
| 2019 | $40.07 Million | $6.90 Million | -$4.85 Million | 5.81x | N/A |
| 2020 | $91.74 Million | $3.20 Million | -$7.67 Million | 28.65x | N/A |
| 2021 | $208.79 Million | $5.78 Million | -$10.30 Million | 36.14x | N/A |
| 2022 | $47.45 Million | $4.52 Million | -$26.85 Million | 10.49x | N/A |
| 2023 | $42.18 Million | $6.63 Million | -$6.74 Million | 6.36x | N/A |
| 2024 | $22.14 Million | $6.28 Million | -$14.24 Million | 3.52x | N/A |
Competitor Companies of UBI by Market Capitalization
Companies near Universal Biosensors Inc in the global market cap rankings as of November 8, 2026. Also see UBI asset base for a full breakdown of the balance sheet.
Key companies related to Universal Biosensors Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Universal Biosensors Inc (2015–2026)
Market capitalization of Universal Biosensors Inc from 2015 to today. Between 2015 and today, Universal Biosensors Inc's market cap moved from $94.91 Million to $ 2.95 Million, with a yearly change of -26.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$2.95 Million | 0.00% |
| 2025 | AU$2.95 Million | -86.67% |
| 2024 | AU$22.14 Million | -47.50% |
| 2023 | AU$42.18 Million | -11.11% |
| 2022 | AU$47.45 Million | -77.27% |
| 2021 | AU$208.79 Million | +127.59% |
| 2020 | AU$91.74 Million | +128.95% |
| 2019 | AU$40.07 Million | -13.64% |
| 2018 | AU$46.40 Million | -26.67% |
| 2017 | AU$63.27 Million | -3.23% |
| 2016 | AU$65.38 Million | -31.11% |
| 2015 | AU$94.91 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Universal Biosensors Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.95 Million USD |
| MoneyControl | $2.95 Million USD |
| MarketWatch | $2.95 Million USD |
| marketcap.company | $2.95 Million USD |
| Reuters | $2.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Universal Biosensors Inc
Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of… Read more